Home > Insider Trading > Filing (0000899243-17-012696)

Filing Details

Accession Number:: 0000899243-17-012696
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-10 21:46:14
Reporting Period:: 2017-05-08

Filing Date:: 2017-05-10
Accepted Time:: 2017-05-10 21:46:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673555	R Lawrence Pernosky	3854 American Way, Suite A Baton Rouge LA 70816	Chief Human Resources Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-08	8,876	$27.35	30,093	No	4	M	Direct
Common Stock	Disposition	2017-05-08	12,281	$58.65	17,812	No	4	S	Direct
Common Stock	Acquisiton	2017-05-09	11,500	$27.35	29,312	No	4	M	Direct
Common Stock	Disposition	2017-05-09	10,900	$58.75	18,412	No	4	S	Direct
Common Stock	Disposition	2017-05-09	600	$59.25	17,812	No	4	S	Direct
Common Stock	Acquisiton	2017-05-10	2,124	$27.35	19,936	No	4	M	Direct
Common Stock	Acquisiton	2017-05-10	5,626	$27.35	25,562	No	4	M	Direct
Common Stock	Acquisiton	2017-05-10	3,750	$27.35	29,312	No	4	M	Direct
Common Stock	Disposition	2017-05-10	11,300	$58.99	18,012	No	4	S	Direct
Common Stock	Disposition	2017-05-10	200	$57.83	17,812	No	4	S	Direct
Common Stock	Disposition	2017-05-08	215	$58.45	0	No	4	S	Indirect	Through 401(k) Plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Through 401(k) Plan

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-05-08	8,876	$0.00	8,876	$27.35
Common Stock	Stock Option (Right to Buy)	Disposition	2017-05-09	11,500	$0.00	11,500	$27.35
Common Stock	Stock Option (Right to Buy)	Disposition	2017-05-10	2,124	$0.00	2,124	$27.35
Common Stock	Stock Option (Right to Buy)	Disposition	2017-05-10	5,626	$0.00	5,626	$27.35
Common Stock	Stock Option (Right to Buy)	Disposition	2017-05-10	3,750	$0.00	3,750	$27.35

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
36,124	2025-05-01	No	4	M	Direct
24,624	2025-05-01	No	4	M	Direct
22,500	2025-05-01	No	4	M	Direct
5,624	2025-05-01	No	4	M	Direct
7,500	2025-05-01	No	4	M	Direct

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $59.06, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.20 to $59.01, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.22 to $59.29, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.27, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.70 to $57.96, inclusive.
The reporting person was granted 45,000 time-based stock options (the "Time-Based Stock Options") on May 1, 2015. The Time-Based Stock Options are subject to time-based vesting conditions. The Time-Based Stock Options vested in equal, 25% installments on each of May 1, 2016 and May 1, 2017 and will vest in equal, 25% installments on each of May 1, 2018 and May 1, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Time-Based Stock Options.
On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2015 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2015, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2015 Tranche Stock Options are subject to additional time-based vesting conditions (2,813 vested on May 1, 2016, 2,813 vested on May 1, 2017, 2,812 will vest on May 1, 2018 and 2,812 will vest on May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2015 Tranche Stock Options.
On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2016 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2016, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2016 Tranche Stock Options are subject to additional time-based vesting conditions (one-third vested on May 1, 2017, and one-third will vest on each of May 1, 2018 and May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2016 Tranche Stock Options.